APT Medical Inc. (SHA:688617)
China · Delayed Price · Currency is CNY 230.00
+1.60 (0.70%)
At close: Feb 6, 2026
APT Medical Revenue
APT Medical had revenue of 653.63M CNY in the quarter ending September 30, 2025, with 24.77% growth. This brings the company's revenue in the last twelve months to 2.41B, up 22.79% year-over-year. In the year 2024, APT Medical had annual revenue of 2.07B with 25.18% growth.
Revenue (ttm)
2.41B
Revenue Growth
+22.79%
P/S Ratio
13.47
Revenue / Employee
942.63K
Employees
2,915
Market Cap
32.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.07B | 415.59M | 25.18% |
| Dec 31, 2023 | 1.65B | 434.19M | 35.71% |
| Dec 31, 2022 | 1.22B | 387.33M | 46.74% |
| Dec 31, 2021 | 828.69M | 349.25M | 72.85% |
| Dec 31, 2020 | 479.44M | 75.47M | 18.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Yuyue Medical Equipment & Supply | 8.08B |
| Lepu Medical Technology (Beijing) | 6.26B |
| Shenzhen New Industries Biomedical Engineering | 4.55B |
| Autobio Diagnostics | 4.22B |
| Shandong Weigao Blood Purification Products | 3.70B |
| MGI Tech | 3.01B |
| Double Medical Technology | 2.48B |
| Jafron Biomedical | 2.04B |